Skip to main content
. 2015 Jan 22;43(4):2188–2198. doi: 10.1093/nar/gku1394

Figure 9.

Figure 9.

Molecular validation of predicted LINE–LINE CNVs identified among healthy individuals by array CGH. (A) Array CGH data indicates a CNV at 2q34 in subject 1 or 2. (B) Schematic representation of the L1PA elements that mediate the CNV and LR-PCR primers testing for the CNV. (C) LR-PCR identifies the presence of a deletion in subject 1. (D) Array CGH data indicates a CNV at 8p23.3 in subject 1 or 2 and subject 5 or 6. (E) Schematic representation of the L1PA elements that mediate the CNVs and LR-PCR primers testing for the CNVs. (F) LR-PCR identifies the presence of homozygous duplications in subjects 1 and 5.